tiprankstipranks
Trending News
More News >
Fattal Holdings 1998 Ltd. (IL:FTAL)
:FTAL
Advertisement

Fattal Hold (FTAL) AI Stock Analysis

Compare
0 Followers

Top Page

IL:FTAL

Fattal Hold

(OTC:FTAL)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
57,564.00
▼(-2.19% Downside)
Fattal Hold's overall stock score is primarily influenced by its strong revenue growth and operational efficiency. However, high leverage, negative free cash flow, and a high P/E ratio suggest potential risks and overvaluation, impacting the overall score negatively.

Fattal Hold (FTAL) vs. iShares MSCI Israel ETF (EIS)

Fattal Hold Business Overview & Revenue Model

Company DescriptionFattal Holdings (1998) Ltd owns and operates hotels. It operates 36 hotels with 9,170 rooms in Israel, as well as approximately 160 Leonardo-branded hotels in Europe. The company was founded in 1998 and is based in Tel Aviv, Israel.
How the Company Makes MoneyFattal Holdings generates revenue through its extensive distribution network, representing and delivering products for numerous international brands. Key revenue streams include the sale of consumer goods, pharmaceuticals, electronics, and food products. The company benefits from strategic partnerships with global brands, enabling it to maintain a diverse portfolio and cater to various market segments. Additionally, its involvement in real estate and manufacturing contributes to its income, leveraging its assets to optimize returns and expand its market presence.

Fattal Hold Financial Statement Overview

Summary
Fattal Hold shows strong revenue growth and operational efficiency with solid EBIT and EBITDA margins. However, high leverage and negative free cash flow present potential risks. Improvement in profitability and debt management is needed.
Income Statement
75
Positive
Fattal Hold has shown strong revenue growth, particularly in the TTM period with a 22.5% increase. Gross profit margins remain healthy at 45.7%, although slightly down from the previous year. The net profit margin is low at 2.5%, indicating room for improvement in profitability. EBIT and EBITDA margins are robust, reflecting efficient operations.
Balance Sheet
60
Neutral
The company has a high debt-to-equity ratio of 5.90, indicating significant leverage, which could pose risks if not managed carefully. Return on equity is modest at 4.7%, suggesting moderate efficiency in using equity to generate profits. The equity ratio is relatively low, reflecting a higher reliance on debt financing.
Cash Flow
55
Neutral
Operating cash flow is positive, but free cash flow is negative, indicating potential liquidity concerns. The free cash flow to net income ratio is low, suggesting challenges in converting income into free cash flow. The operating cash flow to net income ratio is also low, highlighting potential inefficiencies in cash generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.53B7.44B6.93B5.47B3.04B1.90B
Gross Profit3.38B3.46B3.15B2.30B1.56B578.38M
EBITDA2.61B2.75B2.24B1.74B1.45B141.93M
Net Income181.05M278.22M45.19M-78.78M-226.16M-1.31B
Balance Sheet
Total Assets30.28B28.50B26.61B23.56B20.80B21.47B
Cash, Cash Equivalents and Short-Term Investments1.07B660.19M904.26M915.16M776.33M1.29B
Total Debt23.70B22.11B21.31B19.25B17.28B18.06B
Total Liabilities26.09B24.35B23.26B21.00B18.84B19.52B
Stockholders Equity4.13B4.10B3.26B2.48B1.89B1.87B
Cash Flow
Free Cash Flow-570.38M503.95M830.53M-148.92M88.62M-612.02M
Operating Cash Flow884.15M1.04B1.30B741.98M373.56M-253.54M
Investing Cash Flow-2.46B-1.75B-1.08B-1.33B-298.74M-327.44M
Financing Cash Flow1.59B419.93M-185.55M621.41M-499.38M965.72M

Fattal Hold Technical Analysis

Technical Analysis Sentiment
Positive
Last Price58850.00
Price Trends
50DMA
56702.80
Positive
100DMA
55942.50
Positive
200DMA
52621.45
Positive
Market Momentum
MACD
34.69
Negative
RSI
63.58
Neutral
STOCH
85.30
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:FTAL, the sentiment is Positive. The current price of 58850 is above the 20-day moving average (MA) of 53617.50, above the 50-day MA of 56702.80, and above the 200-day MA of 52621.45, indicating a bullish trend. The MACD of 34.69 indicates Negative momentum. The RSI at 63.58 is Neutral, neither overbought nor oversold. The STOCH value of 85.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:FTAL.

Fattal Hold Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
8.14B32.700.74%13.66%-8.18%
58
Neutral
$9.40B50.954.42%4.84%117.70%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
38
Underperform
130.38M-17.92%-61.14%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:FTAL
Fattal Hold
58,850.00
18,440.00
45.63%
IL:DANH
Dan Hotels
2,998.00
615.00
25.81%
IL:ISRO
Isrotel
12,600.00
5,560.84
79.00%
IL:SKLN
Skyline
839.60
-888.40
-51.41%

Fattal Hold Corporate Events

Fattal Holdings Announces Series E Bonds Issuance and Options Exercise
Feb 13, 2025

Fattal Holdings has announced the issuance of Series E bonds and the exercise of non-tradable options for company shares, resulting in a change in the quantity and registry of its securities holders. This development reflects an adjustment in the corporation’s securities landscape, with potential implications for market stakeholders as the company expands its financial instruments.

Fattal Holdings Cancels Public Offer Amid Strategic Bond Issuance
Feb 13, 2025

Fattal Holdings announced the results of its recent offer in the prospectus, revealing the cancellation of the public offer and the issuance of commitment certificates for its Bond E. The total amount of securities offered amounted to 294,791,000 New Shekels, of which 246,574,000 were accepted for public cash consideration. This strategic move indicates a focus on optimizing financial operations and potentially impacts the company’s market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 01, 2025